Celanese Corp: Form 10-K for the period ended Dec 31, 2024
Filed with the SEC on Feb 21, 2025 and accepted by EDGAR at Feb 21, 2025, 21:06 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2024-01-01 to 2024-12-31 | $10.28bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2024-01-01 to 2024-12-31 | $7.92bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2024-01-01 to 2024-12-31 | $2.36bn | us-gaap:GrossProfit |
| Research and development | 12 months2024-01-01 to 2024-12-31 | $130.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2024-01-01 to 2024-12-31 | $1.03bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2024-01-01 to 2024-12-31 | −$697.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2024-01-01 to 2024-12-31 | $676.0m | us-gaap:InterestExpense |
| Income tax | 12 months2024-01-01 to 2024-12-31 | $510.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2024-01-01 to 2024-12-31 | −$1.52bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2024-01-01 to 2024-12-31 | −$13.93 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2024-01-01 to 2024-12-31 | −$13.93 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2024-01-01 to 2024-12-31 | 109,273,779 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2024-01-01 to 2024-12-31 | $966.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2024-01-01 to 2024-12-31 | $435.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2024-01-01 to 2024-12-31 | $307.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2024-01-01 to 2024-12-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | At period end2024-12-31 | $5.14bn | us-gaap:AssetsCurrent |
| Total assets | At period end2024-12-31 | $22.86bn | us-gaap:Assets |
| Current liabilities | At period end2024-12-31 | $3.85bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2024-12-31 | $12.53bn | us-gaap:LongTermDebt |
| Current portion of debt | At period end2024-12-31 | $1.50bn | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2024-12-31 | $5.17bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001306830-25-000027. Last ingested by Listed: Oct 24, 2026, 15:11 ET. Listed shows no prices and gives no investment advice.